These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37471355)

  • 1. Government spending shocks and default risk in emerging markets.
    Jiang M; Li J
    PLoS One; 2023; 18(7):e0288802. PubMed ID: 37471355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sovereign debt responses to the COVID-19 pandemic.
    Zheng H
    J Int Econ; 2023 Jul; 143():103766. PubMed ID: 37192871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In sickness and in debt: The COVID-19 impact on sovereign credit risk.
    Augustin P; Sokolovski V; Subrahmanyam MG; Tomio D
    J financ econ; 2022 Mar; 143(3):1251-1274. PubMed ID: 36268533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public financing of health in developing countries: a cross-national systematic analysis.
    Lu C; Schneider MT; Gubbins P; Leach-Kemon K; Jamison D; Murray CJ
    Lancet; 2010 Apr; 375(9723):1375-87. PubMed ID: 20381856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are Air Pollution, Economic and Non-Economic Factors Associated with Per Capita Health Expenditures? Evidence from Emerging Economies.
    Usman M; Ma Z; Wasif Zafar M; Haseeb A; Ashraf RU
    Int J Environ Res Public Health; 2019 Jun; 16(11):. PubMed ID: 31163652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging markets sovereign CDS spreads during COVID-19: Economics versus epidemiology news.
    Daehler TB; Aizenman J; Jinjarak Y
    Econ Model; 2021 Jul; 100():105504. PubMed ID: 36569375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the Impact of Covid-19 Pandemic on Emerging Market Economies' (EMEs) Sovereign Bond Risk Premium and Fiscal Solvency.
    Bizuneh M; Geremew M
    East Econ J; 2021; 47(4):519-545. PubMed ID: 34538974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sovereign Credit Default Swap and Stock Markets in Central and Eastern European Countries: Are Feedback Effects at Work?
    Anton SG; Afloarei Nucu AE
    Entropy (Basel); 2020 Mar; 22(3):. PubMed ID: 33286112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of the public-debt-to-gdp ratio: can it explain the risk premium of treasury bonds?
    Lagoa SC; Leão ER; Bhimjee DP
    Empirica (Dordr); 2022; 49(4):1089-1122. PubMed ID: 35974978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The COVID-19 pandemic, consumption and sovereign credit risk: Cross-country evidence.
    Hao X; Sun Q; Xie F
    Econ Model; 2022 Apr; 109():105794. PubMed ID: 35153362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future and potential spending on health 2015-40: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries.
    Global Burden of Disease Health Financing Collaborator Network
    Lancet; 2017 May; 389(10083):2005-2030. PubMed ID: 28433260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hong Kong domestic health spending: financial years 1989/90 to 2011/12.
    Tin KY; Tsoi PK; Lee YH; Chong DS; Lam DW; Yeung AY; Ma ES; Maw CK
    Hong Kong Med J; 2015 Jun; 21(3 Suppl 3):1-24. PubMed ID: 26045183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Term spreads and the COVID-19 pandemic: Evidence from international sovereign bond markets.
    Zaremba A; Kizys R; Aharon DY; Umar Z
    Financ Res Lett; 2022 Jan; 44():102042. PubMed ID: 35013673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hong Kong's domestic health spending--financial years 1989/90 through 2004/05.
    Leung GM; Tin KY; Yeung GM; Leung ES; Tsui EL; Lam DW; Tsang CS; Fung AY; Lo SV
    Hong Kong Med J; 2008 Apr; 14 Suppl 2():2-23. PubMed ID: 18587162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hong Kong domestic health spending: financial years 1989/90 to 2010/11.
    Tin KY; Tsoi PK; Lee YH; Tsui EL; Lam DW; Yeung AY; Chui AW; Tay MS
    Hong Kong Med J; 2013 Dec; 19(6 Suppl 7):1-24. PubMed ID: 24356244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hong Kong domestic health spending: financial years 1989/90 to 2009/10.
    Tin KY; Tsoi PK; Lee YH; Tsui EL; Lam DW; Chui AW; Lo SV
    Hong Kong Med J; 2013 Apr; 19(2 Suppl 3):1-24. PubMed ID: 23589588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future health spending forecast in leading emerging BRICS markets in 2030: health policy implications.
    Jakovljevic M; Lamnisos D; Westerman R; Chattu VK; Cerda A
    Health Res Policy Syst; 2022 Feb; 20(1):23. PubMed ID: 35183217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National health expenditures: a global analysis.
    Murray CJ; Govindaraj R; Musgrove P
    Bull World Health Organ; 1994; 72(4):623-37. PubMed ID: 7923542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease burden and government spending on mental, neurological, and substance use disorders, and self-harm: cross-sectional, ecological study of health system response in the Americas.
    Vigo DV; Kestel D; Pendakur K; Thornicroft G; Atun R
    Lancet Public Health; 2019 Feb; 4(2):e89-e96. PubMed ID: 30446416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National spending on health by source for 184 countries between 2013 and 2040.
    Dieleman JL; Templin T; Sadat N; Reidy P; Chapin A; Foreman K; Haakenstad A; Evans T; Murray CJ; Kurowski C
    Lancet; 2016 Jun; 387(10037):2521-35. PubMed ID: 27086174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.